The company is testing its GERD treatment device ahead of an application for FDA trials.
Medigus Ltd. (TASE:MDGS) plans to launch another clinical trial of its SRS System treatment device for Gastroesophageal Reflux Disease (GERD) in India at the Deenanath Mangeshkar Hospital and Research Center in Puna.
The company’s previous medical trial was a success, and the results were received a few days ago. The trials are designed to expand the clinical knowledge about SRS System ahead of an application with the US Food and Drug Administration (FDA) for a clinical trial under FDA protocols.
Published by Globes [online], Israel business news - www.globes.co.il - on August 7, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007